Principia Wealth Advisory, LLC Astrazeneca PLC Transaction History
Principia Wealth Advisory, LLC
- $118 Billion
- Q2 2025
A detailed history of Principia Wealth Advisory, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 56 shares of AZN stock, worth $4,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56Holding current value
$4,736% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,459Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.66 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.64 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...